Archive Uganda

Mapping the Financial Flow and Expenditures for Select MNCH Medicines in Uganda

Since the report of the United Nations Commission on Life-saving Commodities for Women and Children (UNCoLSC) was published in 2012, much has been done to highlight the challenges countries face in ensuring the availability of essential commodities and to create resources to assist countries in this endeavor. In most settings, these commodities are procured with government … Read more

, , ,

Challenges to Ensuring Adequate and Timely Funding for MNCH Commodities

As countries pursue the maternal, newborn, and child health (MNCH) targets established under Sustainable Development Goal 3, they will need to ensure the continuous availability of essential health commodities to prevent and treat the conditions that cause morbidity and mortality in those groups. Since the report of the United Nations Commission on Life-Saving Commodities for … Read more

, , , , , , ,

Implementing QuanTB to Improve Forecasting, Supply Planning, and Early Warning Systems for TB Medicines: Uganda Report

SIAPS conducted a review of SIAPS TB technical assistance and the QuanTB implementation in Uganda. Specific objectives were to determine: Key achievements or results of the SIAPS QuanTB technical assistance in Uganda Experiences and perspectives of the beneficiaries of the NTP Challenges and lessons learned This report summarizes key aspects and results of the Uganda review.

, , , , ,

Approach to the Assessment of Financing of New TB Diagnosis and Treatment Interventions

We carried out case studies in Rwanda and Uganda from July to September 2012 to develop the assessment approach. The studies conducted included a desk review of the Uganda National Tuberculosis and Leprosy Program (NTLP), the Rwanda National TB Program (NTP), and ministry of health documents and budgets from both countries.

, , , , , , , , , ,

Pharmacovigilance Activities in HIV and AIDS Programs in Eight Sub-Saharan African Countries: Opportunities to Enhance Treatment Outcomes and Ensure Patient Safety

Download Monitoring adverse drug reactions is becoming a priority for public health programs involved in large scale-ups of new essential medicines. Under an interagency agreement between the US Food and Drug Administration and the US Agency for International Development (USAID), the SPS program assessed pharmacovigilance activities of 32 PHPs in sub-Saharan Africa. Poster displayed at … Read more

, , , , , , , , , , , , , , , , , ,